$SRRE
SUNRISE REAL ESTATE GROUP INC

2023 Q2 Form 10-K Financial Statement

#000141057823000806 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $7.043M $10.91M $80.02M
YoY Change -79.67% -72.61% 47.8%
Cost Of Revenue $5.956M $9.730M $70.56M
YoY Change -80.2% -66.82% 71.13%
Gross Profit $1.087M $1.183M $9.456M
YoY Change -76.14% -88.76% -26.74%
Gross Profit Margin 15.43% 10.84% 11.82%
Selling, General & Admin $728.7K $5.937M $8.551M
YoY Change -741.49% 1310.83% 159.16%
% of Gross Profit 67.07% 502.05% 90.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$711.8K $441.1K $1.780M
YoY Change -303.37% -6.95% -58.43%
% of Gross Profit -65.51% 37.3% 18.82%
Operating Expenses $1.219M $7.462M $11.58M
YoY Change 1012.6% 443.54% 72.39%
Operating Profit -$132.3K -$6.279M -$2.123M
YoY Change -102.98% -168.67% -134.3%
Interest Expense -$534.0K $2.064M $40.01K
YoY Change 43.73% 1109.86% -95.73%
% of Operating Profit
Other Income/Expense, Net $584.0K $214.6K -$2.730M
YoY Change -126.83% -97.07% -106.46%
Pretax Income $451.6K -$4.000M -$4.853M
YoY Change -80.09% -124.05% -110.02%
Income Tax $250.9K $2.461M $4.543M
% Of Pretax Income 55.55%
Net Earnings $342.0K -$7.468M -$8.429M
YoY Change -75.9% -232.96% -124.05%
Net Earnings / Revenue 4.86% -68.44% -10.53%
Basic Earnings Per Share $0.00 -$0.12
Diluted Earnings Per Share $0.00 -$0.11 -$0.12
COMMON SHARES
Basic Shares Outstanding 68.69M 68.69M 68.69M
Diluted Shares Outstanding 68.69M 68.69M

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.64M $44.16M $44.16M
YoY Change 4.15% 13.84% 13.84%
Cash & Equivalents $64.15M $33.20M $33.20M
Short-Term Investments $10.28M $10.96M $10.96M
Other Short-Term Assets $171.1M $172.0M $172.0M
YoY Change -18.53% -34.94% -34.94%
Inventory
Prepaid Expenses
Receivables $179.3K $204.5K $204.5K
Other Receivables $4.456M $1.859M $19.42M
Total Short-Term Assets $221.3M $235.8M $235.8M
YoY Change -14.29% -26.69% -26.69%
LONG-TERM ASSETS
Property, Plant & Equipment $819.1K $1.001M $23.67M
YoY Change -31.51% -19.16% -14.16%
Goodwill $1.004M $1.243M
YoY Change -32.8% -33.01%
Intangibles
YoY Change
Long-Term Investments $12.29M $12.75M $13.40M
YoY Change -7.12% -10.96% -10.84%
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $35.90M $38.32M $38.32M
YoY Change -12.17% -15.45% -15.45%
TOTAL ASSETS
Total Short-Term Assets $221.3M $235.8M $235.8M
Total Long-Term Assets $35.90M $38.32M $38.32M
Total Assets $257.2M $274.1M $274.1M
YoY Change -14.0% -25.31% -25.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.34M $22.37M $22.37M
YoY Change 13.79% -10.94% -10.94%
Accrued Expenses $448.5K $604.9K $604.9K
YoY Change -33.2% -23.15% -23.15%
Deferred Revenue
YoY Change
Short-Term Debt $1.384M $1.436M $1.436M
YoY Change -7.12% -8.46% -8.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $119.0M $128.3M $128.3M
YoY Change -14.48% -33.91% -33.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $539.2K $1.078M $1.078M
YoY Change -64.29% -51.92% -51.92%
Total Long-Term Liabilities $539.2K $1.078M $1.078M
YoY Change -64.29% -51.92% -51.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $119.0M $128.3M $128.3M
Total Long-Term Liabilities $539.2K $1.078M $1.078M
Total Liabilities $119.5M $129.4M $142.6M
YoY Change -15.02% -34.11% -32.68%
SHAREHOLDERS EQUITY
Retained Earnings $108.0M $109.3M
YoY Change -7.92% -7.16%
Common Stock $8.797M $8.797M
YoY Change 0.69% 0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $125.4M $131.5M $131.5M
YoY Change
Total Liabilities & Shareholders Equity $257.2M $274.1M $274.1M
YoY Change -14.0% -25.31% -25.31%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $342.0K -$7.468M -$8.429M
YoY Change -75.9% -232.96% -124.05%
Depreciation, Depletion And Amortization -$711.8K $441.1K $1.780M
YoY Change -303.37% -6.95% -58.43%
Cash From Operating Activities -$13.21M -$10.77M -$13.17M
YoY Change 60.15% -5639.5% -30.81%
INVESTING ACTIVITIES
Capital Expenditures $1.760K -$2.520K $190.1K
YoY Change -97.65% -96.84% 74.37%
Acquisitions
YoY Change
Other Investing Activities -$2.382M $30.13M $1.816M
YoY Change -435.21% 2456.44% -93.57%
Cash From Investing Activities -$2.384M $30.13M $1.626M
YoY Change -403.48% 2642.22% -94.22%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.860M 4.170M 23.76M
YoY Change -41.43% -31.24% -206.41%
NET CHANGE
Cash From Operating Activities -13.21M -10.77M -13.17M
Cash From Investing Activities -2.384M 30.13M 1.626M
Cash From Financing Activities 3.860M 4.170M 23.76M
Net Change In Cash -11.74M 23.53M -8.300M
YoY Change 1240.95% 219.76% -46.34%
FREE CASH FLOW
Cash From Operating Activities -$13.21M -$10.77M -$13.17M
Capital Expenditures $1.760K -$2.520K $190.1K
Free Cash Flow -$13.21M -$10.77M -$13.37M
YoY Change 58.73% -4027.44% -30.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001083490
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
SUNRISE REAL ESTATE GROUP INC
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022 dei Security Exchange Name
SecurityExchangeName
NONE
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25120074
CY2022Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
0
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-32585
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2713701
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
No. 18, Panlong Road
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
201702
CY2022 dei City Area Code
CityAreaCode
86-21
CY2022 dei Local Phone Number
LocalPhoneNumber
6139-8018
CY2022 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3204973.85
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2140466
CY2022 dei Trading Symbol
TradingSymbol
SRRE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68691925
CY2022 dei Auditor Name
AuditorName
RH CPA
CY2022 dei Auditor Firm
AuditorFirmId
6389
CY2022 dei Auditor Location
AuditorLocation
Bayside, NY
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33201354
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
24901044
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
43869156
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
73010575
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
10960511
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13890946
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
204518
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65850
CY2022Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
120302022
CY2021Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
178685026
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
16502409
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
15837851
CY2022Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
10733460
CY2021Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
15241563
CY2022Q4 us-gaap Assets Current
AssetsCurrent
235773430
CY2021Q4 us-gaap Assets Current
AssetsCurrent
321632855
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001077
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1238416
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
22673139
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
26340669
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
853364
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
12751061
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
14320943
CY2022Q4 us-gaap Other Investments
OtherInvestments
652693
CY2021Q4 us-gaap Other Investments
OtherInvestments
712981
CY2022Q4 us-gaap Goodwill
Goodwill
1243194
CY2021Q4 us-gaap Goodwill
Goodwill
1855655
CY2022Q4 us-gaap Assets
Assets
274094594
CY2021Q4 us-gaap Assets
Assets
366954883
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1435833
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1568455
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
480109
CY2021Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
525396
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22372938
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25120074
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
34742361
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
126175201
CY2022Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
49251273
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
20489304
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7587515
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8819132
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
255175
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
404833
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10303789
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10303789
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1848666
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
683957
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
128277659
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
194090141
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1078422
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2243118
CY2022Q4 us-gaap Liabilities
Liabilities
129356081
CY2021Q4 us-gaap Liabilities
Liabilities
196333259
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68691925
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68691925
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68691925
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68691925
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
686919
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
686919
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8110008
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8050008
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
3986618
CY2021Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
3986618
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
109300636
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
117729224
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9447265
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
24738423
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
131531446
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
155191192
CY2022Q4 us-gaap Minority Interest
MinorityInterest
13207067
CY2021Q4 us-gaap Minority Interest
MinorityInterest
15430432
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144738513
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170621624
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
274094594
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
366954883
CY2022 us-gaap Revenues
Revenues
80020189
CY2021 us-gaap Revenues
Revenues
54140409
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
70563802
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
41233057
CY2022 us-gaap Gross Profit
GrossProfit
9456387
CY2021 us-gaap Gross Profit
GrossProfit
12907352
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3029088
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3417862
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8550561
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3299319
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2123262
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
6190171
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
691096
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
936108
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-651085
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2770136
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41298243
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2730125
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42234351
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4853387
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48424522
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4542509
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-83545766
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7204719
CY2022 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-29472050
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2021 us-gaap Profit Loss
ProfitLoss
46284056
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-967308
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11238667
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8428588
CY2021 us-gaap Net Income Loss
NetIncomeLoss
35045389
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68691925
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68691925
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68691925
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68691925
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2021 us-gaap Profit Loss
ProfitLoss
46284056
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16547215
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3680999
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25943111
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
49965055
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2223365
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
13164962
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23719746
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36800093
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
137778348
CY2021 srre Profit Losses
ProfitLosses
45804056
CY2021 srre Company Cancellation
CompanyCancellation
45288
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
480000
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
17172983
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-3686914
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170621624
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170621624
CY2022 srre Profit Losses
ProfitLosses
-9395896
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
16547215
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144738513
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2021 us-gaap Profit Loss
ProfitLoss
46284056
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1779670
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4281324
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27559
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7666
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
149204
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13264
CY2022 srre Increase Decrease In Net Cash From Directors
IncreaseDecreaseInNetCashFromDirectors
891
CY2021 srre Increase Decrease In Net Cash From Directors
IncreaseDecreaseInNetCashFromDirectors
23148580
CY2022 srre Increase Decrease In Real Estate Property Under Development
IncreaseDecreaseInRealEstatePropertyUnderDevelopment
-44764605
CY2021 srre Increase Decrease In Real Estate Property Under Development
IncreaseDecreaseInRealEstatePropertyUnderDevelopment
8455093
CY2021 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
43324502
CY2022 srre Increase Decrease In Other Receivables And Deposits
IncreaseDecreaseInOtherReceivablesAndDeposits
-3330221
CY2021 srre Increase Decrease In Other Receivables And Deposits
IncreaseDecreaseInOtherReceivablesAndDeposits
300077
CY2022 srre Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-808115
CY2021 srre Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-122863
CY2022 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-901258
CY2021 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
0
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-644540
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
4142878
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-502641
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
31136
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
99955
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-708968
CY2022 srre Increase Decrease In Deferred Government Subsidy
IncreaseDecreaseInDeferredGovernmentSubsidy
0
CY2021 srre Increase Decrease In Deferred Government Subsidy
IncreaseDecreaseInDeferredGovernmentSubsidy
5135878
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-119403
CY2021 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-57580
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13174908
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19042772
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
190148
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
109047
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2022 srre Capital Injection To Unconsolidated Affiliates
CapitalInjectionToUnconsolidatedAffiliates
0
CY2021 srre Capital Injection To Unconsolidated Affiliates
CapitalInjectionToUnconsolidatedAffiliates
0
CY2022 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
CY2021 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
CY2022 srre Proceeds From Transactional Financial Assets
ProceedsFromTransactionalFinancialAssets
1816348
CY2021 srre Proceeds From Transactional Financial Assets
ProceedsFromTransactionalFinancialAssets
11565629
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0
CY2021 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
16690371
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1626200
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28146953
CY2022 srre Proceeds From Affiliate
ProceedsFromAffiliate
0
CY2021 srre Proceeds From Affiliate
ProceedsFromAffiliate
0
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
6869193
CY2022 srre Increase Decrease On Restricted Cash
IncreaseDecreaseOnRestrictedCash
-23759027
CY2021 srre Increase Decrease On Restricted Cash
IncreaseDecreaseOnRestrictedCash
15458728
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23759027
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22327921
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3910009
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2244828
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8300310
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15468568
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24901044
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40369612
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33201354
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24901044
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
4542509
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
345095
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1485288
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable, other receivables and deposits, and amount due from an unconsolidated affiliate. The Company places its cash and cash equivalents with reputable financial institutions with high credit ratings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company conducts credit evaluations of customers and generally does not require collateral or other security from customers. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors relevant to determining the credit risk of specific customers. The amount of receivables ultimately not collected by the Company has generally been consistent with management’s expectations and the allowance established for doubtful accounts.</p>
CY2021Q4 srre Number Of Customer
NumberOfCustomer
0
CY2022Q4 srre Number Of Customer
NumberOfCustomer
0
CY2021 srre Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
CY2022 srre Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
CY2022Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
1
CY2022Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
6.9646
CY2021Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
1
CY2021Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
6.3757
CY2022 srre Real Estate Investment Property Estimated Useful Lives
RealEstateInvestmentPropertyEstimatedUsefulLives
20 years
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 srre Significant Influence Percentage Description
SignificantInfluencePercentageDescription
0.20
CY2021 srre Impairment Loss On Investments Unconsolidated Affiliates
ImpairmentLossOnInvestmentsUnconsolidatedAffiliates
0
CY2022 srre Impairment Loss On Investments Unconsolidated Affiliates
ImpairmentLossOnInvestmentsUnconsolidatedAffiliates
0
CY2021 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2022 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
43869156
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
73010575
CY2021Q4 srre Due To Due From Officers Or Stockholders Current
DueToDueFromOfficersOrStockholdersCurrent
525396
CY2022Q4 us-gaap Due From Employees Current
DueFromEmployeesCurrent
327262
CY2021Q4 us-gaap Due From Employees Current
DueFromEmployeesCurrent
37383
CY2022Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
735860
CY2021Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
803515
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
28153
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
21332
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
7783185
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
12610075
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1859000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1769259
CY2022Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
10733460
CY2021Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
15241563
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1233179
CY2021Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
515604
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1859000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3278646
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3712820
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2277569
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2474404
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001077
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1238416
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
33367887
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
36449956
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
10694748
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
10109287
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
22673139
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
26340669
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1489873
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1489873
CY2021 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2022 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2022Q4 srre Due To Due From Officers Or Stockholders Current
DueToDueFromOfficersOrStockholdersCurrent
480109
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22372938
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
185124
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
272025
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
164566
CY2021Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
110171
CY2022Q4 srre Accrued Bid Bond Current
AccruedBidBondCurrent
90457
CY2021Q4 srre Accrued Bid Bond Current
AccruedBidBondCurrent
103518
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
6954170
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
8122375
CY2022Q4 srre Dividends Payable To Non Controlling Interest Current
DividendsPayableToNonControllingInterestCurrent
193198
CY2021Q4 srre Dividends Payable To Non Controlling Interest Current
DividendsPayableToNonControllingInterestCurrent
211043
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7587515
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8819132
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
35509699
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21166021
CY2022 srre Income Tax Expenses
IncomeTaxExpenses
5569826
CY2021 srre Income Tax Expenses
IncomeTaxExpenses
2140466
CY2017Q4 srre Income Tax Expenses
IncomeTaxExpenses
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.334
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.098
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1569
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.101
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
178251
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
194372
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
122999
CY2022Q4 srre Lessor Operating Lease Payment To Be Received Year Two To Five Years
LessorOperatingLeasePaymentToBeReceivedYearTwoToFiveYears
0
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
122999

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-23-000806-index-headers.html Edgar Link pending
0001410578-23-000806-index.html Edgar Link pending
0001410578-23-000806.txt Edgar Link pending
0001410578-23-000806-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srre-20221231.xsd Edgar Link pending
srre-20221231x10k.htm Edgar Link pending
srre-20221231x10k001.jpg Edgar Link pending
srre-20221231xex31d1.htm Edgar Link pending
srre-20221231xex31d2.htm Edgar Link pending
srre-20221231xex32d1.htm Edgar Link pending
srre-20221231xex32d2.htm Edgar Link pending
srre-20221231xex4d1.htm Edgar Link pending
srre-20221231_def.xml Edgar Link unprocessable
srre-20221231_cal.xml Edgar Link unprocessable
srre-20221231_lab.xml Edgar Link unprocessable
srre-20221231_pre.xml Edgar Link unprocessable
srre-20221231x10k_htm.xml Edgar Link completed